0.90 USD
↗ 0.08 (9.21%)AT CLOSE (11:59 AM EDT)
NeuroSense Therapeutics Ltd. Ordinary Shares
NRSNNASDAQ • USD
0.91
↗ 0.01 (1.61%)
POST MARKET (AS OF 07:22 PM EDT)
Post Market
AS OF 07:22 PM EDT
0.91
↗ 0.01 (1.61%)
Market: CLOSED
Open?$0.83
High?$0.90
Low?$0.83
Prev. Close?$0.82
Volume?186.2K
Avg. Volume?N/A
VWAP?$0.88
Bid / Ask
Bid?$0.91 × 400
Ask?$0.91 × 24.3K
Spread?$0.00
Midpoint?$0.91
Valuation & Ratios
Market Cap?31.7M
Shares Out?32.6M
Float?23.1M
Float %?65.3%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...